Axogen Non Current Liabilities Total vs Total Stockholder Equity Analysis
AXGN Stock | USD 5.97 0.02 0.34% |
Axogen financial indicator trend analysis is way more than just evaluating Axogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axogen Inc is a good investment. Please check the relationship between Axogen Non Current Liabilities Total and its Total Stockholder Equity accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Non Current Liabilities Total vs Total Stockholder Equity
Non Current Liabilities Total vs Total Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axogen Inc Non Current Liabilities Total account and Total Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Axogen's Non Current Liabilities Total and Total Stockholder Equity is 0.4. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Axogen Inc, assuming nothing else is changed. The correlation between historical values of Axogen's Non Current Liabilities Total and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Axogen Inc are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Non Current Liabilities Total i.e., Axogen's Non Current Liabilities Total and Total Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.4 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Non Current Liabilities Total
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most indicators from Axogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. At this time, Axogen's Selling General Administrative is very stable compared to the past year. As of the 17th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.36, though Enterprise Value Over EBITDA is likely to grow to (19.41).
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.4M | 624K | 8.1M | 8.5M | Depreciation And Amortization | 4.5M | 4.6M | 5.6M | 5.8M |
Axogen fundamental ratios Correlations
Click cells to compare fundamentals
Axogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Axogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 154.6M | 201.4M | 208.0M | 195.4M | 196.8M | 206.7M | |
Short Long Term Debt Total | 3.3M | 53.8M | 67.5M | 67.4M | 69.3M | 72.8M | |
Other Current Liab | 10.9M | 17.4M | 16.5M | 13.5M | 17.1M | 18.0M | |
Total Current Liabilities | 20.9M | 22.8M | 24.3M | 23.8M | 30.4M | 32.0M | |
Total Stockholder Equity | 132.2M | 123.1M | 112.6M | 101.0M | 95.7M | 100.4M | |
Property Plant And Equipment Net | 18.1M | 54.1M | 78.1M | 93.7M | 104.3M | 109.5M | |
Net Debt | (32.4M) | 5.0M | 34.7M | 52.1M | 32.3M | 33.9M | |
Retained Earnings | (179.9M) | (203.6M) | (230.6M) | (259.6M) | (281.3M) | (267.2M) | |
Cash | 35.7M | 48.8M | 32.8M | 15.3M | 37.0M | 38.9M | |
Non Current Assets Total | 19.6M | 56.1M | 81.0M | 97.3M | 108.8M | 114.3M | |
Non Currrent Assets Other | (19.6M) | 15.7M | (81.0M) | (97.3M) | (87.6M) | (83.2M) | |
Cash And Short Term Investments | 96.5M | 104.0M | 84.1M | 48.8M | 37.0M | 20.0M | |
Net Receivables | 16.9M | 17.6M | 18.2M | 22.2M | 25.1M | 26.4M | |
Common Stock Shares Outstanding | 39.2M | 40.0M | 41.2M | 42.1M | 42.9M | 45.0M | |
Liabilities And Stockholders Equity | 154.6M | 201.4M | 208.0M | 195.4M | 196.8M | 206.7M | |
Non Current Liabilities Total | 1.6M | 55.4M | 71.2M | 70.6M | 70.7M | 74.3M | |
Inventory | 13.9M | 12.5M | 16.7M | 18.9M | 23.0M | 24.2M | |
Other Stockholder Equity | 311.6M | 326.4M | 342.8M | 360.2M | 376.5M | 395.4M | |
Total Liab | 22.5M | 78.2M | 95.5M | 94.4M | 101.2M | 106.2M | |
Property Plant And Equipment Gross | 18.1M | 54.1M | 85.7M | 93.7M | 118.0M | 123.9M | |
Total Current Assets | 135.0M | 145.3M | 127.0M | 98.1M | 88.0M | 92.4M | |
Short Term Debt | 1.7M | 863K | 1.8M | 1.3M | 1.5M | 1.5M | |
Intangible Assets | 1.5M | 2.1M | 2.9M | 3.6M | 4.5M | 4.8M | |
Other Current Assets | 1.7M | 4.3M | 1.9M | 1.9M | 2.8M | 3.0M | |
Accounts Payable | 8.3M | 4.6M | 5.9M | 9.0M | 11.8M | 12.4M | |
Common Stock Total Equity | 396K | 406K | 417K | 424K | 487.6K | 512.0K | |
Common Stock | 396K | 406K | 417K | 424K | 431K | 452.6K | |
Other Liab | 164K | 112K | 15K | 3K | 2.7K | 2.6K | |
Property Plant Equipment | 18.1M | 38.4M | 78.1M | 93.7M | 107.7M | 113.1M | |
Net Tangible Assets | 130.6M | 121.1M | 109.7M | 97.4M | 112.0M | 58.6M | |
Long Term Debt | 1.6M | 52.9M | 65.6M | 66.1M | 46.6M | 33.6M | |
Long Term Debt Total | 30K | 52.9M | 65.6M | 66.1M | 76.0M | 79.8M | |
Capital Surpluse | 311.6M | 326.4M | 342.8M | 360.2M | 414.2M | 210.4M | |
Short Long Term Debt | 4.7M | 28K | 1.7M | 863K | 776.7K | 737.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Axogen Inc information on this page should be used as a complementary analysis to other Axogen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Axogen Stock analysis
When running Axogen's price analysis, check to measure Axogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axogen is operating at the current time. Most of Axogen's value examination focuses on studying past and present price action to predict the probability of Axogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axogen's price. Additionally, you may evaluate how the addition of Axogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |
Is Axogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.49) | Revenue Per Share 3.804 | Quarterly Revenue Growth 0.129 | Return On Assets (0.06) | Return On Equity (0.22) |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.